v.231201
Showing details for project SYSMHC00076
| SampleID | NumReplicates | Organism | TissueType | CellType | MHCAllele |
|---|---|---|---|---|---|
| SampleID | NumReplicates | Organism | TissueType | CellType | MHCAllele |
| SYSMHC00076_QE_HLAIIp_SA_JMI_RA | 6 | Human | DRB1_0401,DRB1_0801,DRB4_0103,HLA-DQA10301-DQB10302,HLA-DQA10401-DQB10402,HLA-DPA10103-DPB10401,HLA-DPA10207-DPB11901 | ||
| SYSMHC00076_QE_HLAIIp_SA_JMI_RA_CIITA | 6 | Human | DRB1_0401,DRB1_0801,DRB4_0103,HLA-DQA10301-DQB10302,HLA-DQA10401-DQB10402,HLA-DPA10103-DPB10401,HLA-DPA10207-DPB11901 | ||
| SYSMHC00076_QE_HLAIIp_SA_JMI_RA_HROG02 | 2 | Human | DRB1_0301,DRB1_0701,DRB3_0101,DRB4_0103,HLA-DQA10201-DQB10201,HLA-DQA10501-DQB10202,HLA-DPA10103-DPB10401 | ||
| SYSMHC00076_QE_HLAIIp_SA_JMI_RA_HROG02_CIITA | 6 | Human | DRB1_0301,DRB1_0701,DRB3_0101,DRB4_0103,HLA-DQA10201-DQB10201,HLA-DQA10501-DQB10202,HLA-DPA10103-DPB10401 | ||
| SYSMHC00076_QE_HLAIIp_SA_JMI_RA_HROG17 | 4 | Human | DRB1_0102,DRB1_1201,DRB3_0202,HLA-DQA10101-DQB10301,HLA-DQA10505-DQB10501,HLA-DPA10103-DPB10401,HLA-DPA10201-DPB11101 | ||
| SYSMHC00076_QE_HLAIIp_SA_JMI_RA_HROG17_CIITA | 6 | Human | DRB1_0102,DRB1_1201,DRB3_0202,HLA-DQA10101-DQB10301,HLA-DQA10505-DQB10501,HLA-DPA10103-DPB10401,HLA-DPA10201-DPB11101 | ||
| SYSMHC00076_QE_HLAIIp_SA_JMI_RAx | 6 | Human | DRB1_0401,DRB1_0801,DRB4_0103,HLA-DQA10301-DQB10302,HLA-DQA10401-DQB10402,HLA-DPA10103-DPB10401,HLA-DPA10207-DPB11901 | ||
| SYSMHC00076_QE_HLAIIp_SA_JMI_RAx_CIITA | 6 | Human | DRB1_0401,DRB1_0801,DRB4_0103,HLA-DQA10301-DQB10302,HLA-DQA10401-DQB10402,HLA-DPA10103-DPB10401,HLA-DPA10207-DPB11901 | ||
| SYSMHC00076_QE_HLAIp_SA_JMI_RA | 6 | Human | HLA-A02:01,HLA-A24:02,HLA-B35:03,HLA-B51:01,HLA-C04:01,HLA-C14:02 | ||
| SYSMHC00076_QE_HLAIp_SA_JMI_RA_CIITA | 6 | Human | HLA-A02:01,HLA-A24:02,HLA-B35:03,HLA-B51:01,HLA-C04:01,HLA-C14:02 | ||
| SYSMHC00076_QE_HLAIp_SA_JMI_RA_HROG02 | 2 | Human | HLA-A01:01,HLA-A02:01,HLA-B08:01,HLA-B13:02,HLA-C06:02,HLA-C07:01 | ||
| SYSMHC00076_QE_HLAIp_SA_JMI_RA_HROG02_CIITA | 4 | Human | HLA-A01:01,HLA-A02:01,HLA-B08:01,HLA-B13:02,HLA-C06:02,HLA-C07:01 | ||
| SYSMHC00076_QE_HLAIp_SA_JMI_RA_HROG17 | 4 | Human | HLA-A11:01,HLA-A66:01,HLA-B14:02,HLA-B40:02,HLA-C01:02,HLA-C08:02 | ||
| SYSMHC00076_QE_HLAIp_SA_JMI_RA_HROG17_CIITA | 6 | Human | HLA-A11:01,HLA-A66:01,HLA-B14:02,HLA-B40:02,HLA-C01:02,HLA-C08:02 | ||
| SYSMHC00076_QE_HLAIp_SA_JMI_RAx | 6 | Human | HLA-A02:01,HLA-A24:02,HLA-B35:03,HLA-B51:01,HLA-C04:01,HLA-C14:02 | ||
| SYSMHC00076_QE_HLAIp_SA_JMI_RAx_CIITA | 6 | Human | HLA-A02:01,HLA-A24:02,HLA-B35:03,HLA-B51:01,HLA-C04:01,HLA-C14:02 |
Detailed view of sample SYSMHC00076_QE_HLAIIp_SA_JMI_RAx
| ID | SampleID | RawFileName | Organism | Process | Tissue Type | Cell Type | Culture Conditions | Disease State | Comments | MHCClass | MHCAllele | PubMed ID | Peptide | Isolation Method | Antibody | Mass Spectrometer | LC System | iRT Peptides | Acquisition Mode | Fragmentation Method | Gradient | Gradient Length | Flow Rate | Replicate Number |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ID | SampleID | RawFileName | Organism | Process | Tissue_Type | Cell_Type | Culture_Conditions | Disease_State | Comments | MHCClass | MHCAllele | PubMed_ID | Peptide | Isolation_Method | Antibody | Mass_Spectrometer | LC_System | iRT_Peptides | Acquisition_Mode | Fragmentation_Method | Gradient | Gradient_Length | Flow_Rate | Replicate_Number |
| SYSMHC00076 | SYSMHC00076_QE_HLAIIp_SA_JMI_RAx | 20180116_QEh1_LC1_HLAIIp_SA_JMI_RAx_1_R1.raw | Human | In vitro | Glioblastoma | RA | adherent | Glioblastoma | class II | DRB1_0401,DRB1_0801,DRB4_0103,HLA-DQA10301-DQB10302,HLA-DQA10401-DQB10402,HLA-DPA10103-DPB10401,HLA-DPA10207-DPB11901 | PXD020079 | native | Immunoaffinity | HB245 | Q-Exactive HF | no | DDA | HCD | 2-45%(0.1% FA in 2% ACN) | 90 | 1 | |||
| SYSMHC00076 | SYSMHC00076_QE_HLAIIp_SA_JMI_RAx | 20180116_QEh1_LC1_HLAIIp_SA_JMI_RAx_1_R2.raw | Human | In vitro | Glioblastoma | RA | adherent | Glioblastoma | class II | DRB1_0401,DRB1_0801,DRB4_0103,HLA-DQA10301-DQB10302,HLA-DQA10401-DQB10402,HLA-DPA10103-DPB10401,HLA-DPA10207-DPB11901 | PXD020079 | native | Immunoaffinity | HB245 | Q-Exactive HF | no | DDA | HCD | 2-45%(0.1% FA in 2% ACN) | 90 | 2 | |||
| SYSMHC00076 | SYSMHC00076_QE_HLAIIp_SA_JMI_RAx | 20180116_QEh1_LC1_HLAIIp_SA_JMI_RAx_2_R1.raw | Human | In vitro | Glioblastoma | RA | adherent | Glioblastoma | class II | DRB1_0401,DRB1_0801,DRB4_0103,HLA-DQA10301-DQB10302,HLA-DQA10401-DQB10402,HLA-DPA10103-DPB10401,HLA-DPA10207-DPB11901 | PXD020079 | native | Immunoaffinity | HB245 | Q-Exactive HF | no | DDA | HCD | 2-45%(0.1% FA in 2% ACN) | 90 | 3 | |||
| SYSMHC00076 | SYSMHC00076_QE_HLAIIp_SA_JMI_RAx | 20180116_QEh1_LC1_HLAIIp_SA_JMI_RAx_2_R2.raw | Human | In vitro | Glioblastoma | RA | adherent | Glioblastoma | class II | DRB1_0401,DRB1_0801,DRB4_0103,HLA-DQA10301-DQB10302,HLA-DQA10401-DQB10402,HLA-DPA10103-DPB10401,HLA-DPA10207-DPB11901 | PXD020079 | native | Immunoaffinity | HB245 | Q-Exactive HF | no | DDA | HCD | 2-45%(0.1% FA in 2% ACN) | 90 | 4 | |||
| SYSMHC00076 | SYSMHC00076_QE_HLAIIp_SA_JMI_RAx | 20180116_QEh1_LC1_HLAIIp_SA_JMI_RAx_3_R1.raw | Human | In vitro | Glioblastoma | RA | adherent | Glioblastoma | class II | DRB1_0401,DRB1_0801,DRB4_0103,HLA-DQA10301-DQB10302,HLA-DQA10401-DQB10402,HLA-DPA10103-DPB10401,HLA-DPA10207-DPB11901 | PXD020079 | native | Immunoaffinity | HB245 | Q-Exactive HF | no | DDA | HCD | 2-45%(0.1% FA in 2% ACN) | 90 | 5 | |||
| SYSMHC00076 | SYSMHC00076_QE_HLAIIp_SA_JMI_RAx | 20180116_QEh1_LC1_HLAIIp_SA_JMI_RAx_3_R2.raw | Human | In vitro | Glioblastoma | RA | adherent | Glioblastoma | class II | DRB1_0401,DRB1_0801,DRB4_0103,HLA-DQA10301-DQB10302,HLA-DQA10401-DQB10402,HLA-DPA10103-DPB10401,HLA-DPA10207-DPB11901 | PXD020079 | native | Immunoaffinity | HB245 | Q-Exactive HF | no | DDA | HCD | 2-45%(0.1% FA in 2% ACN) | 90 | 6 |